Research on influential factors of innovative drugs development strategy in ChinaDIAO Yuan-yuan, WU Zhi-ang1409-1416
Concerns of the genotoxicity evaluation of drugsGAO Mei, ZHANG Rong, XU Na, CHEN Kai, WANG Xin-xin, ZHANG Dai-zhou1417-1423
Analysis of the current situation of bioequivalence trails of valsartan capsulesLIU Lu-yang, TIAN Li-juan1424-1428
Current status and countermeasures of application of plant growth regulators in the cultivation of Chinese medicinal materialsAN Xiao-jing, LIU Shang-nian, GUO Hao, LI Xian-en, WANG Yan-ting, GUAN Min, GUO Bao-lin, CHEN Cai-xia1429-1436
Analysis on the key points of production quality supervision of the first nasal spray COVID-19 vaccine in ChinaLIU Jing-jing, ZHANG Lai-jun, FU Fei, LI Min, LI Yu-li, HE Huan, WANG Qian-shuo, DONG Chen-di, YE Xiang-zhong, JIANG Jin-qi, LI Wen-dong1437-1441
Mechanism and preclinical evaluation of cytokine release syndrome induced by monoclonal antibodiesFU Ying-shuang, LI Shuang-xing, JIANG Hua, LIN Zhi1442-1448
Progress in oral soluble film for prevention and treatment of nausea and vomitingZHAO Bo-yuan, LI Na, WANG Meng, REN Xiao-liang1449-1457
Applications of new approach methodologies in new drug research and developmentWANG Chun-ming, NIU Zhang-ming, ZHANG Long1458-1465
Pharmacodynamic and pharmacokinetic studies of a novel KRASG12C inhibitor VT198WANG Mei-qing, BAI Hu-cheng, ZHANG Shu, LI Xiao-chuan, WANG Ting-chun, DUAN Xiao-qun1466-1471
Evaluation of key production process of Baoyuan Decoction Granules based on characteristic chromatograms and quantitative transfer relationshipLI Na, DIAO Yuan-yuan, LIU Wei-peng, SHI Yu-wen, JIANG Meng-cheng, LI Jun-ge, QIU Zhi-dong, JIA Ai-ling1472-1481